Join the 200th Anniversary Celebration

Original Article

Effects of Cardiac Sympathetic Innervation on Coronary Blood Flow

Marcelo F. Di Carli, M.D., Michael C. Tobes, M.D., Ph.D., Thomas Mangner, Ph.D., Arlene B. Levine, M.D., Otto Muzik, Ph.D., Pulak Chakroborty, Ph.D., and T. Barry Levine, M.D.

N Engl J Med 1997; 336:1208-1216April 24, 1997

Abstract

Background

The role of cardiac sympathetic nerves in regulating coronary blood flow is controversial. We sought to determine the degree to which cardiac efferent sympathetic signals modulate coronary blood flow. The heterogeneous sympathetic reinnervation in transplanted hearts provides a model for studying the vasomotor responses to adrenergic stimulation in reinnervated and denervated coronary territories of the same heart.

Methods

We studied 14 cardiac-transplant recipients who had normal coronary arteries and no evidence of rejection and 8 normal subjects. We used positron-emission tomography with [11C]hydroxyephedrine, an analogue of norepinephrine, to delineate sympathetic innervation. Using [13N]ammonia, we measured myocardial blood flow at rest, during adenosine-induced hyperemia, and in response to sympathetic stimulation induced by cold pressor testing.

Results

In the transplant recipients, the uptake of [11C]hydroxyephedrine was greater in the territory served by the left anterior descending artery (mean ±SE, 0.15±0.01) than in those served by the right c oronary artery (0.07±0.01, P<0.001) or the circumflex artery (0.09±0.01, P< 0.001). The basal flow was similar in all three regions, as was the percent increase in flow during hyperemia. However, the increase in flow in response to cold pressor testing was higher in the territory of the left anterior descending artery (46±10 percent) than in those of the right coronary artery (16±5 percent, P = 0.01) or the circumflex artery (23±6 percent, P = 0.06), although the changes in hemodynamics and levels of circulating catecholamines were similar. No such regional differences were observed in the normal subjects.

Conclusions

Increases in coronary blood flow in response to sympathetic stimulation correlated with the regional norepinephrine content in the cardiac sympathetic-nerve terminals. These findings suggest that cardiac adrenergic signals play an important part in regulating myocardial blood flow.

Media in This Article

Figure 2Changes in Regional Myocardial Blood Flow in Response to the Cold Pressor Test and the Infusion of Adenosine in the Transplant Recipients and the Normal Subjects.
Figure 1Uptake of [11C]Hydroxyephedrine in Myocardium According to the Coronary Artery Serving the Region Studied.
Article

The coronary microcirculation is a dynamic vascular bed that responds through changes in arteriolar resistance to metabolic tissue demands, changes in blood flow, and neurohormonal stimuli.1-3 Adrenergic stimuli may modulate coronary vasomotor tone at rest or during common activities of daily life that activate the sympathetic nervous system, such as exercise and mental stress. Increased sympathetic activity produces dilatation of coronary resistance vessels and thus increases myocardial blood flow.4,5 This vasodilator response appears to be modulated, at least in part, by endothelial function.5 However, it is not known whether the flow response to sympathetic activation depends on intact efferent function of the sympathetic fibers innervating the large and small coronary arteries or, alternatively, on the increase in circulating catecholamines that accompanies sympathetic activation.

The transplanted heart provides a unique model for studying adrenergic control of the coronary circulation. Cardiac transplantation results in total cardiac denervation due to the sectioning of the postganglionic neural axons that innervate the heart.6 Sympathetic reinnervation has been reported after cardiac transplantation,7,8 but it is only a regional process, favoring the territory of the left anterior descending coronary artery.8,9 Thus, it is possible to study the degree to which cardiac efferent sympathetic signals alter coronary vasomotion by comparing reinnervated and denervated territories in the same heart independently of changes in hemodynamic factors and circulating catecholamines that modulate coronary blood flow. These regions can be defined noninvasively with [11C]hydroxyephedrine, an analogue of norepinephrine, and positron-emission tomographic (PET) imaging.8 Myocardial blood flow can also be quantified by PET with [13N]ammonia,10 a method that allows detailed study of adrenergic control of vascular resistance in the heart.

We sought to study the role of cardiac efferent sympathetic signals in regulating coronary blood flow. We used PET imaging to delineate cardiac sympathetic innervation and measure regional myocardial blood flow in the territories of reinnervated and denervated coronary arteries after cardiac transplantation. Myocardial blood flow was measured at rest, during maximal vasodilatation due to an infusion of adenosine, and in response to sympathetic-nerve stimulation by a cold pressor test. The blood-flow response in the territories of the reinnervated coronary arteries in transplant recipients was compared with that in denervated territories in the same patients.

Methods

Study Population

We studied 14 patients a mean (±SE) interval of 7±1 years (range, 5 to 10) after orthotopic heart transplantation. The patients were selected on the basis of angiographically normal coronary arteries on recent arteriography (performed within the preceding 10±6 months) and the absence of acute rejection as determined by endomyocardial biopsy at the time of the study. The heart transplantations were performed to treat ischemic heart disease in five patients and to treat idiopathic cardiomyopathy in nine. There were 2 women and 12 men (age, 55±9 years). All had normal left ventricular function as assessed by contrast left ventriculography and echocardiography.

Eight healthy volunteers (three men and five women; age, 28±6 years) were studied who were matched for age to the transplanted hearts (age at the time of the study, 31±10 years), and had a low likelihood of coronary artery disease on the basis of the absence of symptoms and risk factors, a normal resting electrocardiogram, and a normal maximal treadmill exercise test. This group was used to establish regional patterns of cardiac sympathetic innervation and to characterize the relations between regional sympathetic efferent signals and myocardial blood flow.

Study Design

The study design was approved by the Human Investigation Committee of Wayne State University, and all the study subjects gave written informed consent. Each subject made two visits to the hospital, during which cardiac sympathetic innervation and regional myocardial blood flow were assessed with a whole-body PET scanner (CTI EXACT HR, Siemens, Knoxville, Tenn.).

All the subjects refrained from drinking caffeine-containing beverages and taking theophylline-containing medications for 24 hours before the PET study. Calcium-channel blockers and beta-blockers were withheld for 24 hours before the study, and arterial vasodilators were withheld for 12 hours. None of the patients received medications known to interfere with catecholamine uptake in presynaptic nerve terminals. All the subjects were studied while fasting.

Assessment of Cardiac Sympathetic-Nerve Terminals

The presence and extent of catecholamine uptake in cardiac sympathetic-nerve terminals were evaluated with [11C]hydroxyephedrine, an analogue of norepinephrine that has the same mechanisms of uptake and storage as the naturally occurring neurotransmitter.11 A 15-minute transmission scan was acquired for the correction of photon attenuation by soft tissue. Beginning with the intravenous bolus administration of [11C]hydroxyephedrine (0.286 mCi per kilogram of body weight), we acquired serial images for 40 minutes (six images for 30 seconds each, two for 60 seconds, two for 150 seconds, two for 300 seconds, and two for 600 seconds). Heart rate and blood pressure were monitored continuously throughout the study.

Assessment of Myocardial Blood Flow

Myocardial blood flow was measured at rest, during a standard intravenous infusion of adenosine (0.14 mg per kilogram per minute), and during cold pressor testing, with [13N]ammonia used as a flow tracer. A 15-minute transmission scan was acquired for correction of photon attenuation. Beginning with the intravenous bolus administration of [13N]ammonia (0.286 mCi per kilogram), images were acquired serially for 20 minutes (12 images for 10 seconds, 3 for 60 seconds, and 3 for 300 seconds). Thirty minutes later, intravenous adenosine was infused for four minutes. Two minutes into the adenosine infusion, a second dose of [13N]ammonia was injected and images were recorded in the same sequence. Thirty minutes later, a cold pressor test was performed by immersing the patient's hand and forearm in ice water for three minutes. Ninety seconds into the cold pressor test, a third dose of [13N]ammonia was injected, and images were recorded in the same acquisition sequence. The patient's movement was minimized by fastening a Velcro strap across his or her chest. The heart rate, systemic blood pressure, and a 12-lead electrocardiogram were recorded at base line and every 60 seconds during and after the infusion of adenosine and the cold pressor test.

Analysis of Data

In each study, the 47 tomographic slices were reoriented into 12 short-axis slices extending from the apex to the base of the left ventricle. To quantify the regional myocardial storage of catecholamines, regions of interest in sectors encompassing the territories of the left anterior descending, circumflex, and right coronary arteries were automatically assigned to each of four midventricular short-axis slices of the [11C]hydroxyephedrine images. An additional small circular region of interest was manually placed in the center of the left ventricular blood pool to quantify the arterial input. The regions of interest were then applied to the entire 40-minute sequence of [11C]hydroxyephedrine images, and regional time–activity curves for myocardial tissue and the blood pool were obtained. In each coronary-artery territory, the fraction of [11C]hydroxyephedrine that was retained was calculated by dividing the concentration in myocardial tissue by the integral of the concentration in arterial blood.

To quantify regional myocardial blood flow, the same regions of interest (the [11C]hydroxyephedrine images) were automatically assigned to each of four midventricular short-axis slices of the [13N]ammonia images, as described previously.12 To ensure that the placement of these regions was identical, the same angle on the circumferential profile was used as the starting point for the sectors of interest on each of the four sets of images studied in each subject. An additional small circular region of interest was manually placed in the center of the left ventricular blood pool to quantify the arterial input. The regions of interest were then copied to the entire sequence of [13N]ammonia images, and regional time–activity curves for myocardial tissue and the blood pool were obtained. In each vascular territory, a single time–activity curve was obtained by averaging the corresponding [13N]ammonia data in adjacent ventricular planes. The curves were then fitted with the use of a previously validated kinetic model of the tracer.10 An index of coronary vascular resistance was calculated as the ratio between the mean aortic blood pressure and the myocardial blood flow. The coronary vasodilator reserve was defined as the ratio between the hyperemic and the basal myocardial blood flows.

Measurement of Circulating Catecholamines

Venous-blood samples for the measurement of circulating catecholamines were obtained from an indwelling venous catheter with the patient at rest (with the patient supine and with little stimulation) and during cold pressor testing. Plasma concentrations of norepinephrine, epinephrine, and dopamine (in picograms per milliliter) were measured by high-performance liquid chromatography.13

Statistical Analysis

Data are presented as means ±SE. Differences between groups were assessed by paired or unpaired Student's t-tests, as appropriate. Differences between multiple groups were studied by a single-factor analysis of variance and by Tukey's test. P values of less than 0.05 were considered to indicate statistical significance. P values of less than 0.10 are also reported, because they were considered to indicate trends toward significance.

Results

Regional Uptake and Storage of Catecholamines

In the transplant recipients, the myocardial uptake of [11C]hydroxyephedrine was consistently lower in the territories of the right coronary artery (0.07± 0.01) and the circumflex artery (0.09±0.01) than in that of the left anterior descending artery (0.15± 0.01; P<0.001 for both comparisons) (Figure 1AFigure 1Uptake of [11C]Hydroxyephedrine in Myocardium According to the Coronary Artery Serving the Region Studied. and Figure 1B). No such differences between regions were noted in the normal subjects.

Systemic Hemodynamics

The heart rate and the rate–pressure product increased with cold pressor testing and adenosine in both groups of subjects. Systolic and mean aortic blood pressure increased during the cold pressor test but remained unchanged during the infusion of adenosine (Table 1Table 1Systemic Hemodynamics in the 14 Transplant Recipients and the 8 Normal Subjects.).

Circulating Catecholamines

Both the transplant recipients and the normal subjects had significant increases in plasma norepinephrine in response to the cold pressor test (Table 2Table 2Circulating Catecholamine Levels at Base Line and in Response to the Cold Pressor Test in the Study Subjects.). Epinephrine levels rose only slightly in the transplant recipients (Table 2).

Regional Myocardial Blood Flow and Coronary Vascular Resistance

Base-Line Measurements

The base-line blood flow in the transplant recipients was similar in all the coronary territories despite the differences in sympathetic reinnervation. The base-line flow was higher in the transplant recipients than in the normal subjects, reflecting the differences in cardiac work and oxygen demand as measured by the rate–pressure product (Table 3Table 3Regional Myocardial Blood Flow and Coronary Vascular Resistance in the Study Subjects.).

Blood-Flow Response to the Cold Pressor Test

During the cold pressor test, blood flow increased significantly in all coronary territories (Table 3). However, the magnitude of the increase in flow differed among regions: it was higher in the territory of the left anterior descending artery (46±10 percent) than in the territories of the right coronary artery (16±5 percent, P = 0.01) and the circumflex artery (23±6 percent, P = 0.06) (Figure 2Figure 2Changes in Regional Myocardial Blood Flow in Response to the Cold Pressor Test and the Infusion of Adenosine in the Transplant Recipients and the Normal Subjects.), even though changes in levels of circulating catecholamines, the heart rate, and blood pressure produce global effects that should affect all the regions equally. The index of coronary vascular resistance decreased, although slightly, only in the territory of the left anterior descending artery. The magnitude of the increase in flow during cold pressor testing exactly mirrored the uptake of [11C]hydroxyephedrine (Table 4Table 4Regional Uptake of [11C]Hydroxyephedrine in the Study Subjects in Relation to the Blood-Flow Response during Cold Pressor Testing and the Adenosine Infusion.). These differences were not observed in the normal subjects (Table 4).

Blood-Flow Response to Adenosine

During hyperemia, blood flow increased and coronary vascular resistance decreased to a similar degree in all the coronary-artery territories in both groups of patients. Although the peak myocardial blood flow was similar in the transplant recipients and the normal subjects, the estimates of coronary vasodilator reserve tended to be higher in the normal subjects because of a lower base-line flow (the denominator of the calculation of coronary flow reserve) (Table 3).

Discussion

Coronary blood flow is regulated to a large extent by adrenergic mechanisms, through the direct activation of adrenergic receptors and indirectly by changes in metabolic autoregulation and endothelial function. However, the importance of cardiac efferent sympathetic signals, as compared with systemic adrenergic influences, in regulating myocardial perfusion remains controversial. Our findings provide evidence that the increase in coronary flow in response to sympathetic stimulation correlates with the magnitude of regional stores of norepinephrine in cardiac sympathetic-nerve terminals. In this study, blood flow increased by 46 percent in the territory of the left anterior descending artery (which had the highest uptake of [11C]hydroxyephedrine) and by only 16 percent in the territory of the right coronary artery (which had the lowest uptake of [11C]hydroxyephedrine) during the cold pressor test. This difference in flow was largely independent of changes in circulating levels of catecholamines and changes in hemodynamics (i.e., heart rate and blood pressure), since we compared reinnervated and denervated coronary territories in the same heart. These findings suggest that cardiac efferent adrenergic signals play an important part in modulating myocardial blood flow during activation of the sympathetic nervous system.

Exactly how the activation of cardiac sympathetic-nerve terminals may cause coronary vasodilatation cannot be determined from this study. Several potential mechanisms could explain our findings, however. It is possible that the increased density of sympathetic-nerve endings in reinnervated regions (i.e., the territory of the left anterior descending artery) caused relatively greater increases in regional contractility and oxygen demand after sympathetic activation, which in turn produced more metabolic vasodilatation. However, Zeiher et al.4 reported similar increases in blood flow in normal coronary arteries in response to the cold pressor test before and after an intracoronary β-adrenergic blockade with propranolol. This would suggest that changes in regional contractility (mediated by β1-adrenoceptors) may not be the determinant dilatory mechanism of resistance vessels during sympathetic stimulation.

Another possibility is that coronary vasodilatation in response to neurally released norepinephrine (a mixed β1- and α-adrenergic agonist) may result from the direct activation of β-adrenergic receptors on smooth muscle and endothelial cells in the vessel wall.3,14 The reported exacerbation of pain after propranolol therapy in patients with classic stable angina or vasospastic angina would support this hypothesis.15,16 However, the findings of Zeiher et al.4 showing that increases in blood flow in response to the cold pressor test are similar before and after treatment with intracoronary propranolol would argue against this mechanism. Finally, coronary vasodilatation may also result from the direct stimulation of α2-adrenergic receptors in intact endothelial cells and the release of nitric oxide,17,18 presumably through the activation of local kinin synthesis.18 Indeed, removing the vascular endothelium of isolated and intact canine arteries enhances the constrictor response to norepinephrine.19,20 In addition, patients with endothelial dysfunction have impaired microvascular dilatation in response to sympathetic stimulation.5 Furthermore, α-adrenergic vasoconstriction is potentiated by the inhibition of nitric oxide synthesis in coronary arteries in both dogs and humans.21

Another important finding in this study is that the basal flows in the transplant recipients were similar in all coronary territories despite the differences in sympathetic innervation, an observation that suggests that resting coronary flow is not substantially affected by either humoral or neural adrenergic influences. This finding is in agreement with the results of studies in animals22 and humans.23 In addition, the maximal vasodilator response to adenosine was similar to that observed in the normal subjects and was not limited by regional differences in sympathetic innervation. This is consistent with the findings of Hodgson et al. demonstrating that coronary flow reserve, as assessed by the use of intracoronary papaverine, was similar in normally innervated and denervated transplant recipients and was unchanged after blockade with either α- or β-adrenergic receptors.23

Data obtained by the noninvasive method of assessing myocardial blood flow in vivo with PET imaging have been shown to be both accurate and reproducible.10,24 Evaluating the presence and severity of intimal disease was not part of our study design. Although it is possible that regional vasomotor dysfunction in territories with transplant-related vasculopathy that was not detected by coronary arteriography may have affected our results, such an effect is not very likely, because transplant-associated atherosclerosis is a diffuse rather than a regional process.25 Furthermore, recent evidence shows that coronary vasomotor function may be preserved in long-term survivors of cardiac transplantation despite the presence of intimal disease.26

Studies have shown the importance of endothelial function in modulating the coronary vasomotor response to increased sympathetic stimulation.5 We have now demonstrated that the response of coronary blood flow to such stimulation is related to the norepinephrine content of cardiac sympathetic-nerve terminals and is largely independent of changes in hemodynamics and levels of circulating catecholamines. These findings suggest that signals from cardiac efferent sympathetic nerves play an important part in modulating the ability of the coronary vasculature to dilate and thus increase the flow of blood to the myocardium during periods of activation of the sympathetic nervous system, such as occurs during exercise, exposure to cold, and mental stress.

This novel mechanism of regulating myocardial perfusion may have several important implications. In patients with progressive transplant-associated atherosclerosis, an inadequate dilator response of resistance vessels distal to the stenosis could further limit the supply of blood to the myocardium and contribute to myocardial ischemia during periods of stress. Such vasomotor dysfunction could accentuate the alterations in myocardial perfusion caused by endothelial dysfunction27 and contribute to the vascular complications of transplant-associated atherosclerosis.28

Furthermore, studies of laboratory animals have shown that brief episodes of reversible ischemia can induce sustained abnormalities in the function of cardiac sympathetic nerves in reperfused myocardium.29-31 Similar findings have also been reported in patients after myocardial infarction.32,33 These observations suggest that severe ischemia may cause regional “denervation” of ischemically injured but viable myocardium. This effect may be important in patients with unstable angina and myocardial infarction. Transient episodes of thrombotic vessel occlusion at the site of plaque rupture are frequent in unstable angina, and coronary occlusion is often intermittent in myocardial infarction.34,35 In addition, the release of vasoactive substances by platelets and vasoconstriction due to endothelial dysfunction may contribute to reduced coronary flow.36 These transient episodes of severe ischemia distal to the site of coronary thrombosis would lead to regional dysfunction of efferent sympathetic nerves, which in turn could reduce the dilator capacity of resistance vessels and influence the extent of myocardial damage. This abnormal vasomotor response may also be present in patients who have diabetic autonomic neuropathy that involves efferent sympathetic pathways. In such patients, impaired coronary vasodilation due to cardiac efferent adrenergic dysfunction may contribute to the pathogenesis of myocardial ischemia and possibly to left ventricular dysfunction.37-39

Supported in part by a grant from the Community Foundation for Southeastern Michigan, Detroit.

We are indebted to Galina Rabkin, Teresa Jones, and Benjamin Lathrop for their expert technical assistance in performing the PET studies; to Drs. M.E. Landa, D. Chugani, J.D. Marsh, and R.J. Spears for their valuable comments; and to Medco Research, Inc., and Fujisawa USA, Inc., for kindly supplying the adenosine.

Source Information

From the Division of Cardiology, Department of Internal Medicine (M.F.D.), and the Department of Radiology (M.F.D., T.M., O.M., P.C.), Wayne State University School of Medicine; and the Henry Ford Heart and Vascular Institute (M.C.T., A.B.L., T.B.L.) — both in Detroit.

Address reprint requests to Dr. Di Carli at the Division of Cardiology, Harper Hospital, 3990 John R. St., Detroit, MI 48201.

References

References

  1. 1

    Berne RM. Regulation of coronary blood flow. Physiol Rev 1964;44:1-29
    Web of Science | Medline

  2. 2

    Vanhoutte PM, ed. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. New York: Raven Press, 1988.

  3. 3

    Young MA, Knight DR, Vatner SF. Autonomic control of large coronary arteries and resistance vessels. Prog Cardiovasc Dis 1987;30:211-234
    CrossRef | Web of Science | Medline

  4. 4

    Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989;14:1181-1190
    CrossRef | Web of Science | Medline

  5. 5

    Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-1992
    Web of Science | Medline

  6. 6

    Norvell JE, Lower RR. Degeneration and regeneration of the nerves of the heart after transplantation. Transplantation 1973;15:337-344
    CrossRef | Web of Science | Medline

  7. 7

    Wilson RF, Christensen BV, Olivari MT, Simon A, White CW, Laxson DD. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. Circulation 1991;83:1210-1220
    Web of Science | Medline

  8. 8

    Schwaiger M, Hutchins GD, Kalff V, et al. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991;87:1681-1690
    CrossRef | Web of Science | Medline

  9. 9

    Wilson RF, Laxson DD, Christensen BV, McGinn AL, Kubo SH. Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation. Circulation 1993;88:165-171
    Web of Science | Medline

  10. 10

    Muzik O, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993;34:83-91
    Web of Science | Medline

  11. 11

    Schwaiger M, Kalff V, Rosenspire K, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990;82:457-464
    CrossRef | Web of Science | Medline

  12. 12

    Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med 1992;33:1243-1250
    Web of Science | Medline

  13. 13

    Goldstein DS, Feuerstein G, Izzo JL Jr, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981;28:467-475
    CrossRef | Web of Science | Medline

  14. 14

    Graves J, Poston L. Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993;108:631-637
    Web of Science | Medline

  15. 15

    Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974;50:534-539
    Web of Science | Medline

  16. 16

    Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Exertional angina pectoris caused by coronary artery spasm: effects of various drugs. Am J Cardiol 1979;43:647-652
    CrossRef | Web of Science | Medline

  17. 17

    Jones CJH, DeFily DV, Patterson JL, Chilian WM. Endothelium-dependent relaxation competes with α1- and α2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 1993;87:1264-1274
    Web of Science | Medline

  18. 18

    Kichuk MR, Seyedi N, Zhang X, et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 1996;94:44-51
    Web of Science | Medline

  19. 19

    Cocks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 1983;305:627-630
    CrossRef | Web of Science | Medline

  20. 20

    Young MA, Vatner SF. Enhanced adrenergic constriction of iliac artery with removal of endothelium in conscious dogs. Am J Physiol 1986;250:H892-H897
    Web of Science | Medline

  21. 21

    Berkenboom G, Unger P, Fang ZY, Fontaine J. Endothelium-derived relaxing factor and protection against contraction to norepinephrine in isolated canine and human coronary arteries. J Cardiovasc Pharmacol 1991;17:Suppl 3:S127-S132
    CrossRef | Web of Science | Medline

  22. 22

    Chilian WM, Boatwright RB, Shoji T, Griggs DM Jr. Evidence against significant resting sympathetic coronary vasoconstrictor tone in the conscious dog. Circ Res 1981;49:866-876
    Web of Science | Medline

  23. 23

    Hodgson JMB, Cohen MD, Szentpetery S, Thames MD. Effects of regional α- and β-blockade on resting and hyperemic coronaryblood flow in conscious, unstressed humans. Circulation 1989;79:797-809
    CrossRef | Web of Science | Medline

  24. 24

    Sawada S, Muzik O, Beanlands R, Wolfe E, Hutchins G, Schwaiger M. Inter observer and inter study variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography. J Nucl Cardiol 1995;2:413-422
    CrossRef | Web of Science | Medline

  25. 25

    Ventura HO, Mehra MR, Smart FW, Stapleton DD. Cardiac allograft vasculopathy: current concepts. Am Heart J 1995;129:791-799
    CrossRef | Web of Science | Medline

  26. 26

    Anderson TJ, Meredith IT, Uehata A, et al. Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation. Circulation 1993;88:1093-1100
    Web of Science | Medline

  27. 27

    Mugge A, Heublein B, Kuhn M, et al. Impaired coronary dilator responses to substance P and impaired flow-dependent dilator responses in heart transplant patients with graft vasculopathy. J Am Coll Cardiol 1993;21:163-170
    CrossRef | Web of Science | Medline

  28. 28

    Schoen FJ, Libby P. Cardiac transplantation graft arteriosclerosis. Trends Cardiovasc Med 1991;1:216-223
    CrossRef | Web of Science | Medline

  29. 29

    Inoue H, Zipes DP. Time course of denervation of efferent sympathetic and vagal nerves after occlusion of the coronary artery in the canine heart. Circ Res 1988;62:1111-1120
    Web of Science | Medline

  30. 30

    Schwaiger M, Guibourg H, Rosenspire K, et al. Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol. J Nucl Med 1990;31:1352-1357
    Web of Science | Medline

  31. 31

    Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991;17:1416-1423
    CrossRef | Web of Science | Medline

  32. 32

    Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519-1526
    CrossRef | Web of Science | Medline

  33. 33

    Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER Jr, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993;22:368-375
    CrossRef | Medline

  34. 34

    Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988;77:1213-1220
    CrossRef | Web of Science | Medline

  35. 35

    Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987;317:1055-1059
    Full Text | Web of Science | Medline

  36. 36

    Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994;90:5-11
    Web of Science | Medline

  37. 37

    Faerman I, Faccio E, Milei R, et al. Autonomic neuropathy and painless myocardial infarction in diabetic patients: histologic evidence of their relationship. Diabetes 1977;26:1147-1158
    CrossRef | Web of Science | Medline

  38. 38

    Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995;25:610-618
    CrossRef | Web of Science | Medline

  39. 39

    Kahn JK, Zola B, Juni JE, Vinik AI. Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol 1986;7:1303-1309
    CrossRef | Web of Science | Medline

Citing Articles (50)

Citing Articles

  1. 1

    Felice Giulio Bonomi, Massimo Nardi, Aldo Fappani, Viviana Zani, Giuseppe Banfi. (2012) Impact of Different Treatment of Whole-Body Cryotherapy on Circulatory Parameters. Archivum Immunologiae et Therapiae Experimentalis
    CrossRef

  2. 2

    Henry Gewirtz. (2012) PET measurement of adenosine stimulated absolute myocardial blood flow for physiological assessment of the coronary circulation. Journal of Nuclear Cardiology
    CrossRef

  3. 3

    Ines Valenta, Vasken Dilsizian, Alessandra Quercioli, Heinrich R. Schelbert, Thomas H. Schindler. (2011) The Influence of Insulin Resistance, Obesity, and Diabetes Mellitus on Vascular Tone and Myocardial Blood Flow. Current Cardiology Reports
    CrossRef

  4. 4

    Mark J. Boogers, Kenji Fukushima, Frank M. Bengel, Jeroen J. Bax. (2011) The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications. Heart Failure Reviews 16:4, 411-423
    CrossRef

  5. 5

    Oliver Gaemperli, Philipp A. Kaufmann. (2011) PET and PET/CT in cardiovascular disease. Annals of the New York Academy of Sciences 1228:1, 109-136
    CrossRef

  6. 6

    Keiichiro Yoshinaga, Osamu Manabe, Nagara Tamaki. (2011) Assessment of coronary endothelial function using PET. Journal of Nuclear Cardiology 18:3, 486-500
    CrossRef

  7. 7

    Keiichiro Yoshinaga, Osamu Manabe, Chietsugu Katoh, Li Chen, Ran Klein, Masanao Naya, Robert A. deKemp, Kathryn Williams, Rob S. B. Beanlands, Nagara Tamaki. (2010) Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET. European Journal of Nuclear Medicine and Molecular Imaging 37:12, 2233-2241
    CrossRef

  8. 8

    Antti Saraste, Hossam Sherif, Markus Schwaiger. 2010. PET Innervation and Receptors. , 140-153.
    CrossRef

  9. 9

    Nagara Tamaki, Keiichiro Yoshinaga, Masanao Naya. (2010) Coronary vasomotor function assessed by positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging 37:6, 1213-1224
    CrossRef

  10. 10

    Oliver Schnell, D. Stalleicken, A. Daiber, N. Marx. (2010) Endothelial function and oxidative stress in diabetes: active profile of the long-acting nitrate pentaerythritol tetranitrate (PETN). Clinical Research in Cardiology Supplements 5:S1, 35-41
    CrossRef

  11. 11

    Rodica Pop-Busui, Laurel Roberts, Subramaniam Pennathur, Mathias Kretzler, Frank C. Brosius, Eva L. Feldman. (2010) The Management of Diabetic Neuropathy in CKD. American Journal of Kidney Diseases 55:2, 365-385
    CrossRef

  12. 12

    James A. Fallavollita, Michael D. Banas, Gen Suzuki, Robert A. deKemp, Munawwar Sajjad, John M. Canty. (2010) 11C-meta-hydroxyephedrine defects persist despite functional improvement in hibernating myocardium. Journal of Nuclear Cardiology 17:1, 85-96
    CrossRef

  13. 13

    Chaim Ross, William H. Frishman, Stephen J. Peterson, Edward Lebovics. (2008) Cardiovascular Considerations in Patients Undergoing Gastrointestinal Endoscopy. Cardiology in Review 16:2, 76-81
    CrossRef

  14. 14

    Michael Jerosch-Herold, Olaf Muehling. (2008) Stress Perfusion Magnetic Resonance Imaging of the Heart. Topics in Magnetic Resonance Imaging 19:1, 33-42
    CrossRef

  15. 15

    Maurizio Galderisi, Arcangelo D’Errico. (2008) β-Blockers and Coronary Flow Reserve. Drugs 68:5, 579-590
    CrossRef

  16. 16

    Tajinder P. Singh, Kimberlee Gauvreau, Jonathan Rhodes, Elizabeth D. Blume. (2007) Longitudinal Changes in Heart Rate Recovery After Maximal Exercise in Pediatric Heart Transplant Recipients: Evidence of Autonomic Re-innervation?. The Journal of Heart and Lung Transplantation 26:12, 1306-1312
    CrossRef

  17. 17

    Sara Del Colle, Fulvio Morello, Franco Rabbia, Alberto Milan, Diego Naso, Elisabetta Puglisi, Paolo Mulatero, Franco Veglio. (2007) Antihypertensive Drugs and the Sympathetic Nervous System. Journal of Cardiovascular Pharmacology 50:5, 487-496
    CrossRef

  18. 18

    G. Cocco, D. Chu. (2007) Stress-induced cardiomyopathy: A review. European Journal of Internal Medicine 18:5, 369-379
    CrossRef

  19. 19

    Riikka Lautamäki, Dnyanesh Tipre, Frank M. Bengel. (2007) Cardiac sympathetic neuronal imaging using PET. European Journal of Nuclear Medicine and Molecular Imaging 34:S1, 74-85
    CrossRef

  20. 20

    Jiyeon Sim, Yeonju Leem, Donguk Kim, Wonwook Ko, Incheol Choi. (2007) The Effect of Thoracic Epidural Lidocaine on Blood Flow of Grafted Coronary Vessels in Coranary Artery Bypass Graft Surgery. Korean Journal of Anesthesiology 52:1, 42
    CrossRef

  21. 21

    Yusuke Nomura, Ichiro Matsunari, Hiroyuki Takamatsu, Yoshihiro Murakami, Takahiro Matsuya, Junichi Taki, Kenichi Nakajima, Stephan G. Nekolla, Wei-Ping Chen, Kouji Kajinami. (2006) Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake. European Journal of Nuclear Medicine and Molecular Imaging 33:8, 871-878
    CrossRef

  22. 22

    Eduardo Aptecar, Philippe Le Corvoisier, Emmanuel Teiger, Patrick Dupouy, Emmanuelle Vermes, Said Sediame, Luc Hittinger, Daniel Loisance, Jean-Luc Dubois-Rande, Olivier Montagne. (2006) Coronary Vasomotor Response to Phenylephrine in Heart Transplant Patients. The Journal of Heart and Lung Transplantation 25:8, 912-920
    CrossRef

  23. 23

    Takahiro Higuchi, Markus Schwaiger. (2006) Imaging cardiac neuronal function and dysfunction. Current Cardiology Reports 8:2, 131-138
    CrossRef

  24. 24

    Mehdi Namdar, Pascal Koepfli, Renate Grathwohl, Patrick T. Siegrist, Michael Klainguti, Tiziano Schepis, Raphael Delaloye, Christophe A. Wyss, Samuel P. Fleischmann, Oliver Gaemperli, Philipp A. Kaufmann. (2006) Caffeine Decreases Exercise-Induced Myocardial Flow Reserve. Journal of the American College of Cardiology 47:2, 405-410
    CrossRef

  25. 25

    Beate R. Jaeger, Frank M. Bengel, Kenichi Odaka, Peter Überfuhr, Carlos A. Labarrere, Stefan Bengsch, Clemens Engelschalk, Eckart Kreuzer, Bruno Reichart, Markus Schwaiger, Dietrich Seidel. (2005) Changes in Myocardial Vasoreactivity After Drastic Reduction of Plasma Fibrinogen and Cholesterol: a Clinical Study in Long-term Heart Transplant Survivors Using Positron Emission Tomography. The Journal of Heart and Lung Transplantation 24:12, 2022-2030
    CrossRef

  26. 26

    A. Nemes, C. Lengyel, T*. Forster, T. T. Varkonyi, R. Takacs, I. Nagy, P. Kempler, J. Lonovics, M. Csanady. (2005) Coronary flow reserve, insulin resistance and blood pressure response to standing in patients with normoglycaemia: is there a relationship?. Diabetic Medicine 22:11, 1614-1618
    CrossRef

  27. 27

    Eric C. Stecker, Katherine R. Strelich, Sumeet S. Chugh, Kathy Crispell, John H. McAnulty. (2005) Arrhythmias After Orthotopic Heart Transplantation. Journal of Cardiac Failure 11:6, 464-472
    CrossRef

  28. 28

    Christophe A Wyss, Pascal Koepfli, Mehdi Namdar, Patrick T Siegrist, Thomas F Luscher, Paolo G Camici, Philipp A Kaufmann. (2005) Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. European Journal of Nuclear Medicine and Molecular Imaging 32:1, 84-91
    CrossRef

  29. 29

    G Óskarsson. (2004) Coronary flow and flow reserve in children. Acta Paediatrica 93, 20-25
    CrossRef

  30. 30

    G.A.J. Jessurun, R.W.M. Hautvast, R.A. Tio, M.J.L. DeJongste. (2003) Electrical neuromodulation improves myocardial perfusion and ameliorates refractory angina pectoris in patients with syndrome X: fad or future?. European Journal of Pain 7:6, 507-512
    CrossRef

  31. 31

    N. Hattori, J. Rihl, F. M. Bengel, S. G. Nekolla, E. Standl, M. Schwaiger, O. Schnell. (2003) Cardiac autonomic dysinnervation and myocardial blood flow in long-term Type 1 diabetic patients. Diabetic Medicine 20:5, 375-381
    CrossRef

  32. 32

    H. P. BÜLOW, F. STAHL, B. LAUER, S. G. NEKOLLA, G. SCHULER, M. SCHWAIGER, F. M. BENGEL. (2003) Alterations of myocardial presynaptic sympathetic innervation in patients with multi-vessel coronary artery disease but without history of myocardial infarction. Nuclear Medicine Communications 24:3, 233-239
    CrossRef

  33. 33

    J Rouleau. (2002) Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition. Autonomic Neuroscience 97:1, 12-18
    CrossRef

  34. 34

    Bengel, Frank M., Ueberfuhr, Peter, Schiepel, Nina, Nekolla, Stephan G., Reichart, Bruno, Schwaiger, Markus, . (2001) Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation. New England Journal of Medicine 345:10, 731-738
    Full Text

  35. 35

    Oliver Schnell. (2001) Cardiac sympathetic innervation and blood flow regulation of the diabetic heart. Diabetes/Metabolism Research and Reviews 17:4, 243-245
    CrossRef

  36. 36

    David M Raffel, Donald M Wieland. (2001) Assessment of cardiac sympathetic nerve integrity with positron emission tomography. Nuclear Medicine and Biology 28:5, 541-559
    CrossRef

  37. 37

    Martin J. Stevens. (2001) New Imaging Techniques for Cardiovascular Autonomic Neuropathy: A Window on the Heart. Diabetes Technology & Therapeutics 3:1, 9-22
    CrossRef

  38. 38

    Nicolas Preumont, Guy Berkenboom, Jean-Luc Vachiery, Jean-Luc Jansens, Martine Antoine, David Wikler, Philippe Damhaut, Serge Degré, André Lenaers, Serge Goldman. (2000) Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries. The Journal of Heart and Lung Transplantation 19:6, 538-545
    CrossRef

  39. 39

    Peter Überfuhr, Axel W Frey, Sibylle Ziegler, Bruno Reichart, Markus Schwaiger. (2000) Sympathetic reinnervation of sinus node and left ventricle after heart transplantation in humans: regional differences assessed by heart rate variability and positron emission tomography. The Journal of Heart and Lung Transplantation 19:4, 317-323
    CrossRef

  40. 40

    Heinrich Wieneke, Christina Zander, Ernst G. Eising, Michael Haude, Andreas Bockisch, Raimund Erbel. (1999) Non-invasive characterization of cardiac microvascular disease by nuclear medicine using single-photon emission tomography. Herz 24:7, 515-521
    CrossRef

  41. 41

    Guido Grassi, Murray Esler. (1999) How to assess sympathetic activity in humans. Journal of Hypertension 17:6, 719-734
    CrossRef

  42. 42

    Gaetano Antonio Lanza. (1999) Abnormal cardiac nerve function in syndrome X. Herz 24:2, 97-106
    CrossRef

  43. 43

    Martin J. Stevens, David M. Raffel, Kevin C. Allman, Markus Schwaiger, Donald M. Wieland. (1999) Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism 48:1, 92-101
    CrossRef

  44. 44

    Marcian E. Van Dort. (1999) Direct chromatographic resolution and isolation of the four stereoisomers ofmeta-hydroxyphenylpropanolamine. Chirality 11:9, 684-688
    CrossRef

  45. 45

    Frank M Bengel, Michael Hauser, Claire S Duvernoy, Andreas Kuehn, Sibylle I Ziegler, Jens C Stollfuss, Mareike Beckmann, Ursula Sauer, Otto Muzik, Markus Schwaiger, John Hess. (1998) Myocardial blood flow and coronary flow reserve late after anatomical correction of transposition of the great arteries. Journal of the American College of Cardiology 32:7, 1955-1961
    CrossRef

  46. 46

    Bodo E. Strauer, Bodo Schwartzkopff, Malte Kelm. (1998) Assessing the coronary circulation in hypertension. Journal of Hypertension 16:9, 1221-1233
    CrossRef

  47. 47

    Lena Luts, Frank Sundler. (1998) AUTOTRANSPLANTATION OF RAT PARATHYROID GLANDS. Transplantation 66:4, 446-453
    CrossRef

  48. 48

    Mike J.L. DeJongste, Raymond W.M. Hautvast, Marcel H.J. Ruiters, Gert J. Ter Horst. (1998) Spinal Cord Stimulation and the Induction of c-fos and Heat Shock Protein 72 in the Central Nervous System of Rats. Neuromodulation: Technology at the Neural Interface 1:2, 73-84
    CrossRef

  49. 49

    Lalouschek, Wolfgang, Müller, Christian, Gamper, Gunnar, Weissel, Michael, Turetschek, Karl, . (1997) Myocardial Ischemia with Normal Coronary Arteries Associated with Thoracic Myelitis. New England Journal of Medicine 337:26, 1920-1920
    Full Text

  50. 50

    David Alexander Sclar. (1997) Pharmaceutical economics & health policy. Clinical Therapeutics 19:3, 538-539
    CrossRef